# ASPEN PARK PHARMACEUTICALS, INC. — Form D

ASPEN PARK PHARMACEUTICALS, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-31. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-03-31
- Form: D
- Accession: 0001670870-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.3M
- Remaining: $750K
- Investors: 9
- Date of first sale: 2016-03-30
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-260428

## Issuer

- Name: ASPEN PARK PHARMACEUTICALS, INC.
- CIK: 0001620965
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 944 PARK AVENUE, NEW YORK, NY, 10028
- Phone: 914-552-2651

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Harry S Fisch, M.D. | Director | New York, NY |
| Mitchell S Steiner | Director | Chicago, IL |
| Harry S Fisch, M.D. | Executive Officer | New York, NY |
| Mitchell S Steiner | Executive Officer | Chicago, IL |
| Harry S Fisch, MD | Director | New York, NY |
| Harry S Fisch, MD | Executive Officer | New York, NY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-10-10](https://search.stillhousedata.com/formd/0001620965-14-000001) | D | $20.0M | — |

## More

- [CIK 1620965 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1620965&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001670870-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.